95 related articles for article (PubMed ID: 2541212)
1. Enhanced glomerular thromboxane A2 mediates some pathophysiologic effect of platelet-activating factor in rabbit nephrotoxic nephritis: evidence from biochemical measurements and inhibitor trials.
Macconi D; Benigni A; Morigi M; Ubiali A; Orisio S; Livio M; Perico N; Bertani T; Remuzzi G; Patrono C
J Lab Clin Med; 1989 May; 113(5):549-60. PubMed ID: 2541212
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of the Korean herbal medicine, Dae-Jo-Whan, on platelet-activating factor-induced platelet aggregation.
Chang GT; Kang SK; Kim JH; Chung KH; Chang YC; Kim CH
J Ethnopharmacol; 2005 Dec; 102(3):430-9. PubMed ID: 16125889
[TBL] [Abstract][Full Text] [Related]
3. Alpha-bulnesene, a novel PAF receptor antagonist isolated from Pogostemon cablin.
Hsu HC; Yang WC; Tsai WJ; Chen CC; Huang HY; Tsai YC
Biochem Biophys Res Commun; 2006 Jul; 345(3):1033-8. PubMed ID: 16712790
[TBL] [Abstract][Full Text] [Related]
4. Effect of thromboxane A2 inhibition and antagonism on prostaglandin and leukotriene synthesis in glomerular immune injury.
Lianos EA; Bresnahan BA
J Lab Clin Med; 1999 Nov; 134(5):478-82. PubMed ID: 10560941
[TBL] [Abstract][Full Text] [Related]
5. Hypoxic pulmonary vasoconstriction in isolated blood-perfused rat lung; modulation by thromboxane A2, platelet-activating factor, cysteinyl leukotrienes and endothelin-1.
Chłopicki S; Bartuś JB; Gryglewski RJ
Pol J Pharmacol; 2002; 54(5):433-41. PubMed ID: 12593530
[TBL] [Abstract][Full Text] [Related]
6. E3040 sulphate, a novel thromboxane synthase inhibitor, blocks the Cl- secretion induced by platelet-activating factor in isolated rat colon.
Sakai H; Suzuki T; Murota M; Oketani K; Uchiumi T; Murakami M; Takeguchi N
Br J Pharmacol; 2002 Jun; 136(3):383-90. PubMed ID: 12023941
[TBL] [Abstract][Full Text] [Related]
7. Role of platelet microparticles in the production of thromboxane by rabbit pulmonary artery.
Pfister SL
Hypertension; 2004 Feb; 43(2):428-33. PubMed ID: 14718367
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of ligustrazine, a modulator of thromboxane-prostacycline-nitric oxide balance, on renal injury in rats with passive Heyman nephritis.
Wang Y; Tong J; Tang R; Dong H; Xu J
Nephron Physiol; 2004; 98(3):p80-8. PubMed ID: 15528953
[TBL] [Abstract][Full Text] [Related]
9. Thromboxane A(2)-mediated Cl(-) secretion induced by platelet-activating factor in isolated rat colon.
Suzuki T; Sakai H; Takeguchi N
Eur J Pharmacol; 2000 Jul; 400(2-3):297-303. PubMed ID: 10988347
[TBL] [Abstract][Full Text] [Related]
10. Approach to dual-acting platelet activating factor (PAF) receptor antagonist/thromboxane synthase inhibitor (TxSI) based on the link of PAF antagonists and TxSIs.
Fujita M; Seki T; Inada H; Shimizu K; Takahama A; Sano T
Bioorg Med Chem Lett; 2002 Feb; 12(3):341-4. PubMed ID: 11814792
[TBL] [Abstract][Full Text] [Related]
11. Role for thromboxane A2 from glomerular thrombi in nephropathy with type 2 diabetic rats.
Okumura M; Imanishi M; Okamura M; Hosoi M; Okada N; Konishi Y; Morikawa T; Miura K; Nakatani T; Fujii S
Life Sci; 2003 May; 72(24):2695-705. PubMed ID: 12679187
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronan-induced cyclooxygenase-2 expression promotes thromboxane A2 production by renal cells.
Sun LK; Beck-Schimmer B; Oertli B; Wüthrich RP
Kidney Int; 2001 Jan; 59(1):190-6. PubMed ID: 11135071
[TBL] [Abstract][Full Text] [Related]
13. Thromboxane A(2) causes retarded clearance of aggregated protein in glomeruli of nephritic mice.
Nagao T; Koseki J; Suzuki Y; Nagamatsu T
Eur J Pharmacol; 2001 Feb; 413(2-3):271-9. PubMed ID: 11226403
[TBL] [Abstract][Full Text] [Related]
14. Eugenol: a dual inhibitor of platelet-activating factor and arachidonic acid metabolism.
Saeed SA; Simjee RU; Shamim G; Gilani AH
Phytomedicine; 1995 Jul; 2(1):23-8. PubMed ID: 23196096
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of COX-1 attenuates the formation of thromboxane A2 and ameliorates the acute decrease in glomerular filtration rate in endotoxemic mice.
Mederle K; Meurer M; Castrop H; Höcherl K
Am J Physiol Renal Physiol; 2015 Aug; 309(4):F332-40. PubMed ID: 26017977
[TBL] [Abstract][Full Text] [Related]
16. Novel agents combining platelet activating factor (PAF) receptor antagonist with thromboxane synthase inhibitor (TxSI).
Fujita M; Seki T; Inada H; Shimizu K; Takahama A; Sano T
Bioorg Med Chem Lett; 2002 Mar; 12(5):771-4. PubMed ID: 11858999
[TBL] [Abstract][Full Text] [Related]
17. The TNF-derived TIP peptide activates the epithelial sodium channel and ameliorates experimental nephrotoxic serum nephritis.
Madaio MP; Czikora I; Kvirkvelia N; McMenamin M; Yue Q; Liu T; Toque HA; Sridhar S; Covington K; Alaisami R; O'Connor PM; Caldwell RW; Chen JK; Clauss M; Brands MW; Eaton DC; Romero MJ; Lucas R
Kidney Int; 2019 Jun; 95(6):1359-1372. PubMed ID: 30905471
[TBL] [Abstract][Full Text] [Related]
18. Syntheses and bioactivities of novel carbamates combining platelet activating factor (PAF) receptor antagonist with thromboxane synthase inhibitor (TxSI).
Fujita M; Seki T
Bioorg Med Chem Lett; 2002 May; 12(10):1383-6. PubMed ID: 11992782
[TBL] [Abstract][Full Text] [Related]
19. Kidney-targeted inhibition of protein kinase C-α ameliorates nephrotoxic nephritis with restoration of mitochondrial dysfunction.
Kvirkvelia N; McMenamin M; Warren M; Jadeja RN; Kodeboyina SK; Sharma A; Zhi W; O'Connor PM; Raju R; Lucas R; Madaio MP
Kidney Int; 2018 Aug; 94(2):280-291. PubMed ID: 29731111
[TBL] [Abstract][Full Text] [Related]
20. Nephrotoxic serum nephritis in chickens.
Chandra M; Marius V; Michele M; Bennejean G; Lamande J; Sternberg M
Avian Pathol; 1986; 15(1):39-56. PubMed ID: 18766503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
